DSG3
Desmoglein-3
Also known as: CDHF6, DSG3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P32926
- Gene
- DSG3
- Ensembl
- ENSG00000134757
- Chromosome
- 18
- Canonical length
- 999 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. The encoded protein has been identified as the autoantigen of the autoimmune blistering disease pemphigus vulgaris. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
999 residues, UniProt reviewed canonical sequence.
>P32926|DSG3
1 MMGLFPRTTG ALAIFVVVIL VHGELRIETK GQYDEEEMTM QQAKRRQKRE WVKFAKPCRE
61 GEDNSKRNPI AKITSDYQAT QKITYRISGV GIDQPPFGIF VVDKNTGDIN ITAIVDREET
121 PSFLITCRAL NAQGLDVEKP LILTVKILDI NDNPPVFSQQ IFMGEIEENS ASNSLVMILN
181 ATDADEPNHL NSKIAFKIVS QEPAGTPMFL LSRNTGEVRT LTNSLDREQA SSYRLVVSGA
241 DKDGEGLSTQ CECNIKVKDV NDNFPMFRDS QYSARIEENI LSSELLRFQV TDLDEEYTDN
301 WLAVYFFTSG NEGNWFEIQT DPRTNEGILK VVKALDYEQL QSVKLSIAVK NKAEFHQSVI
361 SRYRVQSTPV TIQVINVREG IAFRPASKTF TVQKGISSKK LVDYILGTYQ AIDEDTNKAA
421 SNVKYVMGRN DGGYLMIDSK TAEIKFVKNM NRDSTFIVNK TITAEVLAID EYTGKTSTGT
481 VYVRVPDFND NCPTAVLEKD AVCSSSPSVV VSARTLNNRY TGPYTFALED QPVKLPAVWS
541 ITTLNATSAL LRAQEQIPPG VYHISLVLTD SQNNRCEMPR SLTLEVCQCD NRGICGTSYP
601 TTSPGTRYGR PHSGRLGPAA IGLLLLGLLL LLLAPLLLLT CDCGAGSTGG VTGGFIPVPD
661 GSEGTIHQWG IEGAHPEDKE ITNICVPPVT ANGADFMESS EVCTNTYARG TAVEGTSGME
721 MTTKLGAATE SGGAAGFATG TVSGAASGFG AATGVGICSS GQSGTMRTRH STGGTNKDYA
781 DGAISMNFLD SYFSQKAFAC AEEDDGQEAN DCLLIYDNEG ADATGSPVGS VGCCSFIADD
841 LDDSFLDSLG PKFKKLAEIS LGVDGEGKEV QPPSKDSGYG IESCGHPIEV QQTGFVKCQT
901 LSGSQGASAL STSGSVQPAV SIPDPLQHGN YLVTETYSAS GSLVQPSTAG FDPLLTQNVI
961 VTERVICPIS SVPGNLAGPT QLRGSHTMLC TEDPCSRLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against DSG3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 296 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 296 nTPM
- vagina: 116 nTPM
- cervix: 93 nTPM
- tonsil: 68 nTPM
- salivary gland: 38 nTPM
- skin: 38 nTPM
Single-cell type
- esophageal apical cells: 4,224 nCPM
- esophageal suprabasal cells: 3,206 nCPM
- ocular epithelial cells: 2,845 nCPM
- suprabasal keratinocytes: 2,020 nCPM
- esophageal basal cells: 1,626 nCPM
- basal keratinocytes: 1,105 nCPM
Immune cell
- basophil: 8.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
- pons: 0.8 nTPM
- thalamus: 0.8 nTPM
- basal ganglia: 0.7 nTPM
- cerebellum: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DSG3.
Disease | AllUniProt
Conditions DSG3 is implicated in, by any mechanism.
- Blistering, acantholytic, of oral and laryngeal mucosa (ABOLM) MIM:619226
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 202 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Blistering, acantholytic, of oral and laryngeal mucosa
Disease | ImmuneIEDB
Conditions an epitope on DSG3 was assayed in.
- pemphigus B and T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against DSG3 are reported. Each links to that disease's full target list.
- Pemphigus 364
- Blister 22
- Pemphigoid, Bullous 18
- Skin Diseases, Vesiculobullous 7
- Lupus Erythematosus, Systemic 3
Showing 5 of 8 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for DSG3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
427 publications
- Pemphigus.
2019 · Lancet · RCR 20.3 · 397 citations - Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
1997 · J Immunol · RCR 11.3 · 372 citations - Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
1999 · Br J Dermatol · RCR 9.3 · 271 citations - Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris.
1997 · J Cell Biol · RCR 7.9 · 350 citations - Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
1998 · J Clin Invest · RCR 7.1 · 239 citations
Show 20 more of 427 total
- The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
2001 · Br J Dermatol · RCR 6.8 · 190 citations - Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
1997 · J Invest Dermatol · RCR 6 · 184 citations - Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus.
2000 · J Am Acad Dermatol · RCR 5.8 · 159 citations - Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris.
2020 · J Clin Invest · RCR 5.7 · 131 citations - Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
2003 · J Immunol · RCR 5.6 · 264 citations - Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.
2026 · Br J Dermatol · RCR 5 · 5 citations - Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
1995 · Proc Natl Acad Sci U S A · RCR 4.8 · 193 citations - Modern diagnosis of autoimmune blistering skin diseases.
2010 · Autoimmun Rev · RCR 4.7 · 134 citations - Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.
1996 · J Invest Dermatol · RCR 4.5 · 172 citations - Paraneoplastic pemphigus in children and adolescents.
2002 · Br J Dermatol · RCR 4.4 · 120 citations - Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
2000 · J Clin Invest · RCR 4.4 · 196 citations - Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
2005 · J Clin Invest · RCR 4.2 · 191 citations - ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
2009 · Arch Dermatol · RCR 4.2 · 120 citations - Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
2006 · J Biol Chem · RCR 4.2 · 181 citations - A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
2006 · Arch Dermatol · RCR 4.1 · 118 citations - Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis.
2017 · J Invest Dermatol · RCR 4 · 107 citations - Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
2010 · Exp Dermatol · RCR 3.8 · 102 citations - Autoimmunity against desmosomal cadherins in pemphigus.
1999 · J Dermatol Sci · RCR 3.7 · 137 citations - Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
2020 · JAMA Dermatol · RCR 3.7 · 55 citations - Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
2012 · J Clin Invest · RCR 3.7 · 140 citations
Reference: B cellIEDB
5 publications
- Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.
1995 · Proc Natl Acad Sci U S A · RCR 3.9 · 151 citations - Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.
2006 · J Transl Med · RCR 0.8 · 26 citations - Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
2012 · J Dermatol Sci · RCR 0.3 · 9 citations - The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
2013 · J Pept Sci · RCR 0.1 · 3 citations - Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide.
2016 · Clin Exp Dermatol
Reference: T cellIEDB
10 publications
- Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
1995 · Proc Natl Acad Sci U S A · RCR 4.8 · 193 citations - Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
1997 · J Clin Invest · RCR 3.3 · 134 citations - Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
2024 · J Invest Dermatol · RCR 2.8 · 12 citations - Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
1998 · J Invest Dermatol · RCR 2.5 · 99 citations - T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.
2004 · J Immunol · RCR 1.9 · 87 citations
Show 5 more
- Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus.
2021 · J Invest Dermatol · RCR 1.9 · 25 citations - The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
2024 · Br J Dermatol · RCR 1.5 · 6 citations - T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris.
2003 · J Invest Dermatol · RCR 0.4 · 13 citations - Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.
2007 · Clin Immunol · RCR 0.3 · 16 citations - Characterization of desmoglein-3 epitope region peptides as synthetic antigens: analysis of their in vitro T cell stimulating efficacy, cytotoxicity, stability, and their conformational features.
2015 · J Pept Sci
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- adherens junction assembly
- cell-cell adhesion
- desmosome assembly
- homophilic cell adhesion via plasma membrane adhesion molecules
- negative regulation of cell migration
- negative regulation of p38MAPK cascade
- positive regulation of bicellular tight junction assembly
- positive regulation of protein localization to membrane
- regulation of protein stability
- tight junction assembly
- positive regulation of protein localization to adherens junction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DSG3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DSG3 as an antibody target. Whether an autoantibody or antibody against DSG3 could matter depends on whether native DSG3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DSG3 is annotated at the cell surface, where native DSG3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- The encoded protein has been identified as the autoantigen of the autoimmune blistering disease pemphigus vulgaris.
Loading the interactive Seroatlas protein explorer...